|
|
|
Volumn 11, Issue 2, 2006, Pages 267-271
|
|
The American Association for the Study of Liver Diseases: New perspectives in the treatment of hepatitis C
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
AMANTADINE;
AMMONIUM TRICHLORO(DIOXYETHYLENE O,O')TELLURATE;
ANA 975;
ANTIRETROVIRUS AGENT;
ANTIVIRUS AGENT;
CILUPREVIR;
CPG 10101;
ENZYME INHIBITOR;
GAMMA INTERFERON;
INTERMUNE A;
INTERMUNE B;
ISATORIBINE;
NIM 811;
NM 283;
PEGINTERFERON;
PEGINTERFERON ALPHA2A;
PEGINTERFERON ALPHA2B;
PROTEINASE INHIBITOR;
RIBAMIDINE;
RIBAVIRIN;
SCH 503034;
UNCLASSIFIED DRUG;
VALOPICITABINE;
VIRUS PROTEIN;
VX 950;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTINUING EDUCATION;
HEADACHE;
HEPATITIS C;
HUMAN;
LIVER DISEASE;
MEDICAL SOCIETY;
NONHUMAN;
PRIORITY JOURNAL;
AMANTADINE;
ANTIVIRAL AGENTS;
HEPACIVIRUS;
HEPATITIS C;
HUMANS;
INTERFERONS;
MUTATION;
PATIENT COMPLIANCE;
VIRAL HEPATITIS VACCINES;
|
|
EID: 33645515557
PISSN: 13596535
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (4)
|
|
References (2)
|
